018214266

WELTRUZA

---

March 22, 2020

Trademark Summary

The trademark application WELTRUZA was filed by Teva Pharmaceuticals USA Inc., a U.S. corporation (the "Applicant"). The application was published for oppositions on May 18, 2020, and it was registered by office on August 25, 2020 without any oppositions.

The application was filed in Dutch (English was selected as the second language).

Change of name and address of the trademark registration was recorded on August 20, 2020. Appointment and Replacement of representative of the trademark registration was recorded on March 30, 2022.

---

Goods And Services

• The mark was filed in class 5 with following description of goods:
  
  1. Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease
  2. Pharmaceutical preparations for the prevention and treatment of depression
  3. Pharmaceutical preparations for the prevention and treatment of psychological disorders
  4. Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy
  5. Pharmaceutical preparations for the prevention and treatment of cardiovascular and blood pressure disorders
  6. Pharmaceutical preparations for the prevention and treatment of irritable bowel syndrome
  7. Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders
  8. Pharmaceutical preparations for the prevention and treatment of osteoporosis
  9. Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain
  10. Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders
  11. Pharmaceutical preparations for the prevention and treatment of digestive tract, gastrointestinal and dermatological diseases and disorders
  12. Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders
  13. Pharmaceutical preparations for the prevention and treatment of sexual dysfunction
  14. Pharmaceutical preparations for the prevention and treatment of symptoms associated with uterine fibroids
  15. Pharmaceutical preparations for the prevention and treatment of urinary incontinence and overactive bladder
  16. Pharmaceutical preparations for the prevention and treatment of AIDS-related disorders
  17. Pharmaceutical preparations that support, encourage and promote bone strength
  18. Pharmaceutical preparations that support, encourage and promote bone health
  19. Pharmaceutical preparations used in the treatment of bone disorders and bone diseases
  20. Pharmaceutical preparations, namely injectable contraceptives
  21. Pharmaceutical preparations, namely, contraceptive preparations
  22. Pharmaceutical preparations, namely fertility enhancement preparations
  23. Pharmaceutical preparations, namely, hormone replacement therapy preparations
  24. Pharmaceutical preparations for the treatment of cancer
  25. Pharmaceutical agents affecting the central nervous system
  26. Pharmaceutical agents affecting circulatory systems
  27. Pharmaceutical agents affecting sensory organs
  28. Pharmaceutical agents affecting urogenital organs
  29. Pharmaceutical agents affecting peripheral nervous system
  30. Pharmaceutical preparations for the treatment of neurological disorders.